Rocket Doctor AI Upsizes Private Placement to $4.5 Million on Strong Demand

Rocket Doctor AI ( (TSE:AIDR) ) just unveiled an update.

Rocket Doctor AI Inc. has increased the size of its previously announced non-brokered private placement under the listed issuer financing exemption to a maximum of $4.5 million in gross proceeds, with units priced at $0.70 each, citing strong investor demand while keeping all other terms of the offering unchanged. The upsized financing underscores growing market interest in the company’s AI-powered healthcare technology and is expected to bolster its capacity to scale its digital health platforms and decision support systems, potentially strengthening its competitive position in virtual care and expanding its reach into underserved markets in Canada and the U.S.

The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.78 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.

Spark’s Take on TSE:AIDR Stock

According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.

The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.

To see Spark’s full report on TSE:AIDR stock, click here.

More about Rocket Doctor AI

Rocket Doctor AI Inc. operates in the digital health and medical AI industry, providing physician-built, AI-powered solutions aimed at making high-quality healthcare accessible across the patient journey. Its cornerstone technology, the Global Library of Medicine, is a clinically validated decision support system developed with input from hundreds of physicians worldwide. Through its affiliated AI-driven digital health platform and marketplace, Rocket Doctor has supported more than 300 physicians in delivering over 700,000 patient visits, enabling virtual and hybrid practices that reduce administrative burdens, improve care consistency, and expand access for underserved, rural and remote communities in Canada as well as Medicaid and Medicare patients in the United States.

YTD Price Performance: 8.22%

Average Trading Volume: 242,099

Technical Sentiment Signal: Buy

Current Market Cap: C$67.13M

For a thorough assessment of AIDR stock, go to TipRanks’ Stock Analysis page.